Jove
Visualize
Contact Us

Related Experiment Videos

Mette Melander Visby1, Kristina Juul Hare1,2

  • 1Institut for Klinisk Medicin, Københavns Universitet.

Ugeskrift for Laeger
|November 13, 2024
PubMed
Summary

Iron deficiency anemia, common in women with heavy periods, can be effectively treated with intravenous iron. This case shows rapid hemoglobin increase, offering an alternative to blood transfusions.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Hematology
  • Gynecology

Background:

  • Iron deficiency anemia (IDA) is a prevalent condition, particularly in premenopausal women, often linked to heavy menstrual bleeding (HMB).
  • Uterine fibroids can exacerbate menstrual blood loss, contributing to IDA.

Observation:

  • An asymptomatic premenopausal woman presented with severe iron deficiency anemia (hemoglobin 3.9 mmol/l).
  • The patient had uterine fibroids and was scheduled for myomectomy.

Findings:

  • Intravenous (IV) iron therapy was administered to the patient.
  • Fourteen days post-infusion, her hemoglobin level significantly increased to 6.3 mmol/l.

Implications:

  • Highlights the critical need for screening women for HMB and resultant IDA.
  • Emphasizes IV iron therapy as a viable alternative to blood transfusion for IDA treatment.
  • Encourages proactive iron supplementation in at-risk populations.